Peregrine Pharma New (PPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPHM | IMMX | SABS | ||
| Company | Peregrine Pharma New | Immix Biopharma Inc | Sab Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.24 | 5.71 | 3.99 | ||
| High | 4.25 | 5.89 | 4.05 | ||
| Low | 4.18 | 5.58 | 3.84 | ||
| Latest | 4.22 | 5.72 | 3.99 | ||
| Change | +0.03 | +0.01 | +0.04 | ||
| % Change | +0.72% | +0.18% | +1.01% | ||
| Volume | 93,000 | 832,700 | 824,500 | ||
| 20-Day Average Volume | 254,905 | 1,331,960 | 349,050 | ||
| Previous Close | 4.19 | 5.71 | 3.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.24 | 5.36 | 3.86 | ||
| 20-Day Raw Stochastic | 27.59% | 49.11% | 77.53% | ||
| 20-Day Relative Strength | 48.73 | 59.67 | 59.87 | ||
| Weighted Alpha | +32.90 | +122.53 | +39.87 | ||
| Today's Opinion | N/A | 96% Buy | 100% Buy | ||
| Previous Opinion | N/A | 96% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 12/29/17 | -19.09% since 12/12/25 | +4.72% since 12/12/25 | ||
| Low | 3.88 on 01/02/18 | 5.33 on 12/17/25 | 3.76 on 12/15/25 | ||
| High | 4.25 on 01/05/18 | 7.17 on 12/15/25 | 4.05 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | -19.77% since 12/05/17 | +35.22% since 11/19/25 | +4.18% since 11/19/25 | ||
| Low | 3.74 on 12/21/17 | 3.78 on 12/03/25 | 3.30 on 12/08/25 | ||
| High | 5.48 on 12/11/17 | 7.73 on 12/12/25 | 4.19 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +23.39% since 10/05/17 | +161.19% since 09/19/25 | +61.54% since 09/19/25 | ||
| Low | 3.28 on 10/09/17 | 1.98 on 09/25/25 | 1.85 on 09/30/25 | ||
| High | 5.48 on 12/11/17 | 7.73 on 12/12/25 | 4.19 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | -4.31% since 07/05/17 | +139.33% since 06/18/25 | +124.16% since 06/18/25 | ||
| Low | 2.85 on 09/08/17 | 1.94 on 09/17/25 | 1.67 on 06/30/25 | ||
| High | 5.78 on 07/14/17 | 7.73 on 12/12/25 | 6.60 on 07/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 190,786 | 192,066 | 189,952 | ||
| Shares Outstanding, K | 45,210 | 33,578 | 47,607 | ||
| Annual Sales | 57,630,000 | 0 | 1,320,000 | ||
| Annual Net Income | -28,160,000 | -21,610,000 | -34,110,000 | ||
| Last Quarter Sales | 12,780,000 | 0 | 0 | ||
| Last Quarter Net Income | -12,620,000 | -7,590,000 | 45,450,000 | ||
| 60-Month Beta | 2.74 | 0.33 | 0.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 09/11/17 | -0.24 on 11/07/25 | -0.21 on 11/14/25 | ||
| Latest Earnings Date | 03/12/18 | 03/23/26 | 03/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||